Telepsychology for Benzodiazepines Withdrawal in Adults Suffering From Hypnotic-dependent Insomnia

Inclusion Criteria: * French speaker * Had benzodiazepines and related drugs prescribed to improving sleep, for a minimum of 4 nights per week and for at least 6 months * Pathological Benzodiazepine Dependence Questionnaire (BDEPQ) score (\>34). * Motivated to stop hypnotic treatment (score \>5 on a 1 to 10 degrees VAS) * Subjective complaints of difficulties initiating and/or maintaining sleep for a minimum of 3 nights per week and for at least 6 months, and 4) presence of marked distress or impaired daytime functioning (fatigue, impaired attention and/or concentration). Because hypnotic medications may mask an underlying insomnia problem, participants should meet these criteria either currently (while taking medication) or after previous attempts to discontinue the medication. These criteria are consistent with those for primary insomnia and hypnotic-dependent insomnia. * Present the diagnoses of insomnia (307.42) and sedative, hypnotic and anxiolytic use disorder (304.10) from the DSM V. * Having e-literacy (being familiar with emails, videoconferencing, online questionnaires and Internet use) Exclusion Criteria: * In acute treatment for psychological or psychiatric problems (e.g., current participation in psychotherapy) * Be participating in a tapering BZD protocol, or similar * Currently receiving an active prescription for any antipsychotic medication * Using non-BZRA sedative-hypnotics for treating insomnia or related sleep problems (e.g., trazodone, quetiapine, tri…